AmbioPharm is a full-service peptide manufacturing company headquartered in North Augusta, South Carolina. In addition to our USA headquarters, we have manufacturing facilities in the USA and Shanghai, China.
We have developed and offer leading, highly-efficient processes for manufacturing peptides at small to very large scale.
We provide products and services to Pharmaceutical companies and Clinical Research labs.
We manufacture peptide APIs for some of the world’s largest biotech and pharmaceutical companies, but we can also handle small batch projects.
AmbioPharm has multiple manufacturing suites capable of producing peptide APIs (Active Pharmaceutical Ingredients) at varying scales from gram to multi-kilogram scale. We use solid phase synthesis, solution phase synthesis, and hybrid solid/solution phase synthesis to produce peptide APIs.
All our processes comply with cGMP (Current Good Manufacturing Practice) regulations as required by the FDA.
Besides contract peptide API manufacturing, we also partner with generic drug companies to develop generic peptide drugs for established commercial markets throughout the world.
We produce cGMP grade peptides used in clinical and diagnostic applications. These include reference peptide standards for their internal controls and measurements. In addition, we also provide process development and optimization services and analytical services too for non-GMP and cGMP peptides.
These services are available for a broad range of customers, including Universities, Research Organizations, Biotech Companies, Big Pharma, and others.